News

Apr 26, 2017

Mitotech's SkQ1 improved visual acuity in Leber's Hereditary Optic Neuropathy (LHON) patients

Apr 20, 2017

Mitotech’s SkQ1 and its potential for treating age-related disorders discussed in Fierce Biotech publication

Mar 21, 2017

Mitotech's lead compound significantly increased lifespan of rapidly aging mice

Feb 10, 2017

Mitotech discusses SkQ1 and Dry Eye Disease in a recent Fierce Biotech article

Feb 7, 2017

Mitotech will attend the Biotech and Money conference in London, Feb 7-8, 2017

Jan 20, 2017

Mitotech S.A. Developing a Dry Eye Treatment has been Granted Two U.S. Patents for Pharmaceutical Formulations

Sep 9, 2016

Mitotech S.A. is granted a patent in anti-aging

Jul 27, 2016

Mitotech S.A. announces its Ophthalmic Scientific Advisory Board

Mar 20, 2016

Oxidative stress and dry eye in Review of Ophthalmology

Mar 1, 2016

Mitotech S.A. to present at ARVO 2016

Feb 5, 2016

Mitotech CEO to present at the annual BIO CEO and Investor Conference 2016

Jan 25, 2016

Mitotech S.A. to initiate its first clinical study of a systemic formulation of SkQ1

Jan 10, 2016

Results of SkQ1 U.S. Phase 2 Clinical Study in Patients with Dry Eye Syndrome published in Advances in Therapy journal

Dec 27, 2015

Results of Mitotech’s Multicenter Clinical Study in Patients with Dry Eye Syndrome published in Advances in Therapy journal

Oct 16, 2015

Mitotech S.A. to present at the 2015 Sofinnova Japan Biopharma Partnering Conference

May 3, 2015

Mitotech’s posters at ARVO 2015 in Denver, May 3-7

Apr 23, 2015

Mitotech Announces Phase 2 Data Showing Positive Effect of SkQ1 in Patients with Dry Eye Syndrome

Apr 21, 2014

Mitotech S.A. announces the initiation of Phase II clinical trial in Dry Eye Patients Utilizing the Controlled Adverse Environment

May 14, 2013

Mitotech completes series of uveitis studies

Dec 9, 2012

Mitotech’s posters at ARVO 2015 in Denver, May 3-7

Jan 17, 2012

Mitotech initiated pre-clinical program for SkQ1 compound in the U.S.